Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Times Interest Earned (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Times Interest Earned for 9 consecutive years, with -$3.65 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 69.58% year-over-year to -$3.65, compared with a TTM value of -$8.3 through Dec 2025, up 28.84%, and an annual FY2025 reading of -$11.11, changed 0.11% over the prior year.
  • Times Interest Earned was -$3.65 for Q4 2025 at Enanta Pharmaceuticals, up from -$7.7 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$3.65 in Q4 2025 and bottomed at -$18.38 in Q2 2023.
  • Average Times Interest Earned over 3 years is -$11.12, with a median of -$11.57 recorded in 2024.
  • The sharpest move saw Times Interest Earned fell 18.36% in 2024, then skyrocketed 69.58% in 2025.
  • Year by year, Times Interest Earned stood at -$10.14 in 2023, then fell by 18.36% to -$12.0 in 2024, then surged by 69.58% to -$3.65 in 2025.
  • Business Quant data shows Times Interest Earned for ENTA at -$3.65 in Q4 2025, -$7.7 in Q3 2025, and -$11.68 in Q2 2025.